SCHEMBL23905305

SCHEMBL23905305

COC(=O)c1cc(OC)c2nc(Cl)c(F)cc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.44
ALDH1A1 P00352 2/20 0.44
PTPN11 Q06124 2/20 0.42
CYP3A4 P08684 1/20 0.42
MAPT P10636 4/20 0.39
POLB P06746 2/20 0.39
GAA P10253 2/20 0.39
LMNA P02545 1/20 0.39
NFKB1 P19838 1/20 0.39
XDH P47989 1/20 0.39
GFER P55789 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
FUT7 Q11130 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CNR2 P34972 1/20 0.38
KMT2A Q03164 3/20 0.38
GLA P06280 1/20 0.38
CA12 O43570 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25114393 0.87 KDM4E (0.47) KDM4EALDH1A1PTPN11CYP3A4MAPT
SCHEMBL23905738 0.87 HSD17B2 (0.46) ALDH1A1PTPN11MAPTPOLBGAA
SCHEMBL30596879 0.84 KDM4E (0.45) KDM4EALDH1A1PTPN11CYP3A4MAPT
SCHEMBL23930154 0.84 KDM4E (0.45) KDM4EALDH1A1PTPN11CYP3A4MAPT
SCHEMBL26110237 0.83 KDM4E (0.44) KDM4EALDH1A1PTPN11CYP3A4MAPT
SCHEMBL30596874 0.83 KDM4E (0.44) KDM4EALDH1A1PTPN11CYP3A4MAPT
SCHEMBL23904780 0.82 KDM4E (0.43) KDM4EALDH1A1PTPN11CYP3A4MAPT
SCHEMBL23905296 0.81 KDM4E (0.42) KDM4EALDH1A1PTPN11CYP3A4MAPT
SCHEMBL23905306 0.80 KDM4E (0.41) KDM4EALDH1A1PTPN11CYP3A4MAPT
SCHEMBL23905313 0.80 ALDH1A1 (0.41) KDM4EALDH1A1PTPN11CYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021198981-A1 ANTIVIRAL COMPOUNDS AND USES THEREOF Janssen Biopharma, Inc. (US) 2021-10-07 WO disclosed